ProQR Therapeutics N.V. (PRQR)
USD 1.99
(15.7%)
USD 1.99
(15.7%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -99.27 Million EUR | -36.36% |
| 2022 | -72.8 Million EUR | 42.74% |
| 2021 | -127.15 Million EUR | -205.94% |
| 2020 | -41.56 Million EUR | 57.76% |
| 2019 | -98.39 Million EUR | -2.28% |
| 2018 | -96.19 Million EUR | -135.45% |
| 2017 | -40.85 Million EUR | 23.64% |
| 2016 | -53.5 Million EUR | 40.57% |
| 2015 | -90.02 Million EUR | 18.06% |
| 2014 | -109.87 Million EUR | -18554.16% |
| 2013 | -589 Thousand EUR | -284.97% |
| 2012 | -153 Thousand EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -68.01 Million EUR | 31.49% |
| 2024 Q2 | -61.35 Million EUR | 12.11% |
| 2023 Q1 | -117.56 Million EUR | -61.48% |
| 2023 Q4 | -99.27 Million EUR | 0.01% |
| 2023 Q3 | -99.28 Million EUR | 7.24% |
| 2023 FY | -99.27 Million EUR | -36.36% |
| 2023 Q2 | -107.03 Million EUR | 8.96% |
| 2022 Q1 | -107.14 Million EUR | 15.74% |
| 2022 Q3 | -78.21 Million EUR | 18.08% |
| 2022 Q4 | -72.8 Million EUR | 6.92% |
| 2022 FY | -72.8 Million EUR | 42.74% |
| 2022 Q2 | -95.47 Million EUR | 10.9% |
| 2021 Q1 | -33.58 Million EUR | 19.19% |
| 2021 Q3 | -120.33 Million EUR | -15.64% |
| 2021 Q2 | -104.05 Million EUR | -209.83% |
| 2021 FY | -127.15 Million EUR | -205.94% |
| 2021 Q4 | -127.15 Million EUR | -5.67% |
| 2020 FY | -41.56 Million EUR | 57.76% |
| 2020 Q4 | -41.56 Million EUR | 24.85% |
| 2020 Q3 | -55.3 Million EUR | 32.17% |
| 2020 Q2 | -81.54 Million EUR | 3.05% |
| 2020 Q1 | -84.1 Million EUR | 14.52% |
| 2019 Q2 | -70.14 Million EUR | 14.15% |
| 2019 FY | -98.39 Million EUR | -2.28% |
| 2019 Q1 | -81.7 Million EUR | 15.07% |
| 2019 Q4 | -98.39 Million EUR | -55.85% |
| 2019 Q3 | -63.13 Million EUR | 9.99% |
| 2018 Q2 | -24.94 Million EUR | 17.61% |
| 2018 Q3 | -105.39 Million EUR | -322.51% |
| 2018 Q4 | -96.19 Million EUR | 8.73% |
| 2018 FY | -96.19 Million EUR | -135.45% |
| 2018 Q1 | -30.27 Million EUR | 25.9% |
| 2017 Q2 | -36.23 Million EUR | 21.69% |
| 2017 Q3 | -33.25 Million EUR | 8.22% |
| 2017 Q4 | -40.85 Million EUR | -22.84% |
| 2017 FY | -40.85 Million EUR | 23.64% |
| 2017 Q1 | -46.27 Million EUR | 13.52% |
| 2016 Q3 | -59.52 Million EUR | 16.21% |
| 2016 FY | -53.5 Million EUR | 40.57% |
| 2016 Q2 | -71.04 Million EUR | 11.55% |
| 2016 Q1 | -80.31 Million EUR | 10.78% |
| 2016 Q4 | -53.5 Million EUR | 10.12% |
| 2015 Q2 | -102.12 Million EUR | 7.91% |
| 2015 Q1 | -110.89 Million EUR | -0.93% |
| 2015 FY | -90.02 Million EUR | 18.06% |
| 2015 Q4 | -90.02 Million EUR | 5.89% |
| 2015 Q3 | -95.65 Million EUR | 6.33% |
| 2014 Q2 | -35.44 Million EUR | 0.0% |
| 2014 Q3 | -112.45 Million EUR | -217.26% |
| 2014 Q4 | -109.87 Million EUR | 2.29% |
| 2014 FY | -109.87 Million EUR | -18554.16% |
| 2013 FY | -589 Thousand EUR | -284.97% |
| 2013 Q4 | -589 Thousand EUR | 0.0% |
| 2012 FY | -153 Thousand EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Absci Corporation | -72.59 Million USD | -36.743% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 160.397% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 105.309% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -131676.86% |
| Apollomics, Inc. | -27.39 Million USD | -262.376% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -15039.277% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -12.223% |
| Bicycle Therapeutics plc | -481.46 Million USD | 79.381% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 23.112% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 374.515% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 2488.662% |
| Chimerix, Inc. | -25.51 Million USD | -289.046% |
| CRISPR Therapeutics AG | -150.84 Million USD | 34.189% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 155.876% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 64.005% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1395.144% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1395.144% |
| Gritstone bio, Inc. | 39.49 Million USD | 351.387% |
| Allakos Inc. | -24.97 Million USD | -297.489% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -361.498% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1001.073% |
| Cytokinetics, Incorporated | 642.37 Million USD | 115.454% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -38.373% |
| Innoviva, Inc. | 255.56 Million USD | 138.845% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -974.708% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 13586.94% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -144.683% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -1669.484% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -25.15% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -160.272% |
| ImmuCell Corporation | 10.99 Million USD | 1003.255% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 35.598% |
| Incyte Corporation | -3.17 Billion USD | 96.873% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 724.421% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -8255.345% |
| Mustang Bio, Inc. | -3.73 Million USD | -2557.194% |
| MiMedx Group, Inc. | -33.9 Million USD | -192.831% |
| MEI Pharma, Inc. | -3.7 Million USD | -2579.427% |
| MacroGenics, Inc. | -66.98 Million USD | -48.202% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -1266.249% |
| Mereo BioPharma Group plc | -51.46 Million USD | -92.879% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -556.937% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -871.929% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 375.719% |
| Minerva Neurosciences, Inc. | 41 Million USD | 342.104% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -346.531% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -3811.457% |
| NextCure, Inc. | -6.47 Million USD | -1432.697% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -243.838% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -96.576% |
| Onconetix, Inc. | 5.33 Million USD | 1962.027% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -1456.244% |
| Opthea Limited | 28.15 Million USD | 452.563% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 623.585% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 1539.863% |
| PDS Biotechnology Corporation | -32.7 Million USD | -203.504% |
| Precigen, Inc. | -481 Thousand USD | -20538.832% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -470.664% |
| Prime Medicine, Inc. | -27.94 Million USD | -255.294% |
| PureTech Health plc | -167.19 Million USD | 40.625% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -221.667% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -266.32% |
| Replimune Group, Inc. | 1.41 Million USD | 7130.65% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -727.846% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 457.186% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -4184.49% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 83.678% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -436.034% |
| Sesen Bio, Inc. | -112.55 Million USD | 11.799% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -1298.208% |
| Solid Biosciences Inc. | -47.75 Million USD | -107.901% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 66.206% |
| SciSparc Ltd. | -2.06 Million USD | -4707.399% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 187.48% |
| TG Therapeutics, Inc. | 17.86 Million USD | 655.776% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -555.915% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -1499.111% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 128.641% |
| UroGen Pharma Ltd. | 4.39 Million USD | 2360.824% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -313.0% |
| XOMA Corporation | -29 Million USD | -242.32% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 659.756% |
| AbCellera Biologics Inc. | -55.94 Million USD | -77.463% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -616.461% |
| Cassava Sciences, Inc. | -121.13 Million USD | 18.048% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 1524.68% |
| Precision BioSciences, Inc. | -85.41 Million USD | -16.231% |
| Dyadic International, Inc. | -6.37 Million USD | -1456.463% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1082.1% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -523.064% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -225.912% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -198.502% |
| IGM Biosciences, Inc. | -72.6 Million USD | -36.728% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -141.041% |
| Acelyrin, Inc. | -216.9 Million USD | 54.232% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -994.156% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -491.297% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1062.013% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 68.663% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -28.175% |
| Senti Biosciences, Inc. | 1.74 Million USD | 5805.332% |
| Mesoblast Limited | 55.96 Million USD | 277.39% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -292.507% |
| ChromaDex Corporation | -24.04 Million USD | -312.811% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -11415.375% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 262.059% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -1234.646% |
| Seer, Inc. | -4.24 Million USD | -2241.339% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 161.377% |
| Novavax, Inc. | -298.29 Million USD | 66.72% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -985.956% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 260.985% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -1914.464% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -20.36% |
| Celcuity Inc. | 6.78 Million USD | 1563.443% |
| ContextLogic Inc. | -232 Million USD | 57.21% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 59.04% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 10.19% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 102.163% |
| Amarin Corporation plc | -191.04 Million USD | 48.036% |
| AnaptysBio, Inc. | -18.15 Million USD | -446.927% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -762.716% |
| Aptorum Group Limited | 1.35 Million USD | 7415.359% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -50.514% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 2419.457% |
| Ardelyx, Inc. | 34.51 Million USD | 387.647% |
| Celularity Inc. | 65.19 Million USD | 252.282% |
| Omeros Corporation | 331.17 Million USD | 129.976% |
| Humacyte, Inc. | -22.48 Million USD | -341.487% |
| Immunocore Holdings plc | -358.59 Million USD | 72.316% |
| IO Biotech, Inc. | -140.69 Million USD | 29.443% |
| GT Biopharma, Inc. | -1.02 Million USD | -9623.093% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 47.257% |
| Summit Therapeutics Inc. | 34.67 Million USD | 386.303% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -1537.624% |
| Pulmatrix, Inc. | -10.41 Million USD | -852.988% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 10.888% |
| Evogene Ltd. | -19.63 Million USD | -405.617% |
| CorMedix Inc. | -43.05 Million USD | -130.585% |
| BioLineRx Ltd. | 7.33 Million USD | 1453.228% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 15.185% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -32.233% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 44.533% |
| scPharmaceuticals Inc. | -6.54 Million USD | -1416.773% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -573.401% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 26.682% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 13586.94% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -436.034% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 52.31% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -7.018% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -345.409% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 46.225% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -272.38% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 916.169% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -494.727% |
| Daré Bioscience, Inc. | -5.15 Million USD | -1824.67% |
| bluebird bio, Inc. | 108.57 Million USD | 191.436% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 126.211% |
| DBV Technologies S.A. | -126.98 Million USD | 21.824% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 43.347% |
| Galecto, Inc. | -21.21 Million USD | -367.915% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -1359.25% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -8.223% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -46.457% |
| GlycoMimetics, Inc. | -40.98 Million USD | -142.221% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 185.145% |
| ADMA Biologics, Inc. | 90.06 Million USD | 210.222% |
| Clene Inc. | 3.34 Million USD | 3072.239% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 71.152% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1111.403% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -3072.65% |
| Soligenix, Inc. | -4.95 Million USD | -1904.864% |
| Century Therapeutics, Inc. | 847 Thousand USD | 11820.517% |
| Kura Oncology, Inc. | -20.11 Million USD | -393.453% |
| Surrozen, Inc. | -32.66 Million USD | -203.921% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -142.567% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 5549.473% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -3005.185% |
| Autolus Therapeutics plc | -186.59 Million USD | 46.799% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -101.348% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 389.695% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -319.279% |
| GRI Bio, Inc. | -1.79 Million USD | -5433.6% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1005.113% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 1960.086% |
| INmune Bio, Inc. | -25.41 Million USD | -290.669% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 165.765% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -95.963% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -510.933% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -968.457% |
| Jaguar Health, Inc. | 29.39 Million USD | 437.766% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -3341.086% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 361.141% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 805.012% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 411.346% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 126.266% |
| Verastem, Inc. | -37.27 Million USD | -166.304% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -91.417% |
| Histogen Inc. | -7.48 Million USD | -1225.935% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -359.451% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 24.48% |
| Surrozen, Inc. | -32.66 Million USD | -203.921% |
| Organovo Holdings, Inc. | -1.5 Million USD | -6487.444% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -2261.676% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1084.477% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -128.518% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -581.03% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -13648.55% |
| Kronos Bio, Inc. | -36.05 Million USD | -175.345% |
| Turnstone Biologics Corp. | -14.58 Million USD | -580.697% |
| Synaptogenix, Inc. | -28.66 Million USD | -246.363% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -10506.066% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 15907.768% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 303.712% |
| Exelixis, Inc. | -73.05 Million USD | -35.897% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -313.413% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 58.871% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -18.04% |
| ESSA Pharma Inc. | -33.62 Million USD | -195.265% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -3671.562% |
| Avid Bioservices, Inc. | 169.72 Million USD | 158.489% |
| Insmed Incorporated | 721.62 Million USD | 113.757% |
| MediWound Ltd. | -5.32 Million USD | -1765.328% |
| OmniAb, Inc. | 9.2 Million USD | 1178.7% |
| Alector, Inc. | -35.63 Million USD | -178.567% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 215.472% |
| Zai Lab Limited | -775 Million USD | 87.191% |
| AlloVir, Inc. | -62.69 Million USD | -58.35% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 129.15% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -653.722% |
| Aura Biosciences, Inc. | -21.52 Million USD | -361.198% |
| Immunic, Inc. | -45.34 Million USD | -118.952% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 48.621% |
| Veracyte, Inc. | -203.82 Million USD | 51.295% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 115.553% |
| FibroGen, Inc. | 56.76 Million USD | 274.878% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1214.798% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 25.959% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -3411.493% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -4694.98% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -2871.349% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 40.184% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 106.326% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -305.659% |
| XBiotech Inc. | -200.02 Million USD | 50.369% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -18.04% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 68.654% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -5658.282% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 2292.42% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -181.521% |
| Agenus Inc. | 274.13 Million USD | 136.213% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -28.562% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 1844.382% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 41.746% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -7.468% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 113.483% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -821.962% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -78.503% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -2775.244% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1005.974% |
| Lantern Pharma Inc. | -21.7 Million USD | -357.409% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -2247.429% |
| Ainos, Inc. | 4.07 Million USD | 2534.393% |
| Pluri Inc. | 22.82 Million USD | 534.854% |
| Prothena Corporation plc | -608.34 Million USD | 83.682% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 16.406% |
| Rallybio Corporation | -24.1 Million USD | -311.886% |
| Kodiak Sciences Inc. | -103.87 Million USD | 4.431% |
| Cue Biopharma, Inc. | -33.81 Million USD | -193.541% |
| MeiraGTx Holdings plc | -40.3 Million USD | -146.322% |
| Annexon, Inc. | -193.75 Million USD | 48.764% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -467.305% |
| Moderna, Inc. | -2.9 Billion USD | 96.585% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -303.958% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -221.261% |
| Blueprint Medicines Corporation | 702.83 Million USD | 114.125% |
| Immix Biopharma, Inc. | -17.5 Million USD | -466.956% |
| CalciMedica, Inc. | -5.53 Million USD | -1695.168% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -20.973% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -147.953% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 40.991% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -198.538% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -1560.913% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -65.609% |
| Nutriband Inc. | -251.65 Thousand USD | -39347.653% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -190.96% |
| Vor Biopharma Inc. | 4.3 Million USD | 2408.669% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 98.355% |
| Alkermes plc | -166.73 Million USD | 40.462% |
| ProKidney Corp. | -56.23 Million USD | -76.529% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -103.963% |
| Arcellx, Inc. | -296.95 Million USD | 66.57% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 107.279% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -261.452% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 315.123% |
| Atai Life Sciences N.V. | -28.55 Million USD | -247.618% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 4550.638% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -335.102% |
| MediciNova, Inc. | -50.78 Million USD | -95.482% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -25.973% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -441210.425% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1438.495% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 50.319% |
| Biomea Fusion, Inc. | -166.57 Million USD | 40.402% |
| RenovoRx, Inc. | -1.17 Million USD | -8363.153% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -4.67% |
| Geron Corporation | 14.76 Million USD | 772.534% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2274.174% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 57.655% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -5.373% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -3.738% |
| Royalty Pharma plc | 5.65 Billion USD | 101.754% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -154.07% |
| Imunon, Inc. | -4.21 Million USD | -2255.868% |
| BioAtla, Inc. | -109.01 Million USD | 8.933% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 929.624% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -368.202% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 29.459% |
| Structure Therapeutics Inc. | -124.33 Million USD | 20.16% |
| 89bio, Inc. | -289.05 Million USD | 65.656% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -499.473% |
| aTyr Pharma, Inc. | -7.44 Million USD | -1232.699% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 20.35% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -21.392% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -11454.31% |
| Akari Therapeutics, Plc | -3.84 Million USD | -2481.867% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 6217.037% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 107.189% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 218.749% |
| Liquidia Corporation | -80.17 Million USD | -23.819% |
| Entera Bio Ltd. | -10.62 Million USD | -833.98% |
| GH Research PLC | -78.07 Million USD | -27.147% |
| Vericel Corporation | 1.27 Million USD | 7873.906% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -465.206% |
| Xencor, Inc. | 29.64 Million USD | 434.883% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -4939.708% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -510.933% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -40434.723% |
| Vaxcyte, Inc. | -368.22 Million USD | 73.04% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 27.927% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 21.472% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -8255.345% |
| Portage Biotech Inc. | -4.98 Million USD | -1893.029% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -441210.425% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -50.136% |
| OncoCyte Corporation | -6.56 Million USD | -1412.613% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 11162.106% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -2079.117% |
| Purple Biotech Ltd. | -14.13 Million USD | -602.17% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -434.616% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -1594.075% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -68.771% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -317.885% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -332.072% |
| United Therapeutics Corporation | -507.7 Million USD | 80.447% |
| HilleVax, Inc. | -165.48 Million USD | 40.011% |
| Silo Pharma, Inc. | -3.52 Million USD | -2716.802% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 99602.631% |
| Pharming Group N.V. | 109.8 Million USD | 190.409% |
| Tharimmune, Inc. | -10.93 Million USD | -807.815% |
| Genprex, Inc. | -6.73 Million USD | -1373.408% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 14.628% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 73.083% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1073.74% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -6985.852% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -2892.897% |
| OKYO Pharma Limited | -826.84 Thousand USD | -11906.17% |
| Savara Inc. | 153 Thousand USD | 64984.17% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 893.484% |
| Curis, Inc. | -23.88 Million USD | -315.593% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -12692.686% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 8477.45% |
| BeiGene, Ltd. | -2.25 Billion USD | 95.594% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 46.508% |
| Erasca, Inc. | -37.21 Million USD | -166.748% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -7608.154% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -7608.154% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -858.972% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -813.441% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -216.448% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -207.613% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -188.785% |
| Adicet Bio, Inc. | -138.78 Million USD | 28.471% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 150.121% |
| Aditxt, Inc. | 18.12 Million USD | 647.836% |
| Adagene Inc. | -87.62 Million USD | -13.29% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -2283.255% |
| Quantum-Si incorporated | -118.55 Million USD | 16.266% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -1228.208% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -104.648% |
| Compugen Ltd. | -12.9 Million USD | -669.318% |
| Generation Bio Co. | 31.44 Million USD | 415.673% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 43.39% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -221.032% |
| Invivyd, Inc. | -198.47 Million USD | 49.982% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -9.973% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -4040.354% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -40.236% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -1354.546% |
| 2seventy bio, Inc. | 181.71 Million USD | 154.631% |
| Instil Bio, Inc. | 75.35 Million USD | 231.735% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -992.987% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -3085.534% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1438.495% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -281.823% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -2326.278% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -1805.793% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 23.814% |
| Evaxion Biotech A/S | 5.28 Million USD | 1977.732% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 11.811% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 24.377% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -92.725% |
| Cingulate Inc. | 3.08 Million USD | 3320.337% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -3280.074% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 1481.283% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 5.94% |
| Clearmind Medicine Inc. | -3.94 Million USD | -2417.928% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1155.083% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 6908.24% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -82.971% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 674.562% |
| ImmunityBio, Inc. | 618.22 Million USD | 116.058% |
| Korro Bio, Inc. | -132.94 Million USD | 25.327% |
| Kineta, Inc. | -4.54 Million USD | -2086.144% |
| BioVie Inc. | -17.73 Million USD | -459.84% |
| Codexis, Inc. | -43.27 Million USD | -129.421% |
| Celularity Inc. | 65.19 Million USD | 252.282% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 233.935% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -3032.622% |
| Virax Biolabs Group Limited | -3.36 Million USD | -2850.206% |
| Cibus, Inc. | -8.07 Million USD | -1128.928% |
| IN8bio, Inc. | -16.38 Million USD | -505.728% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 275857.722% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -2725.869% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 109.416% |
| Eyenovia, Inc. | 1.25 Million USD | 7986.917% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 468.975% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -2961.14% |
| Elevation Oncology, Inc. | -19.11 Million USD | -419.263% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -198.592% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -408.935% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -68.616% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -378.954% |
| Moolec Science SA | 117.61 Thousand USD | 84504.146% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -158.53% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -161.809% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 29.803% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -341.31% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -1320.328% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -1751.117% |
| Humacyte, Inc. | -22.48 Million USD | -341.487% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -293.284% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -5467.739% |
| Genelux Corporation | -6.89 Million USD | -1338.944% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -219.626% |
| Notable Labs, Ltd. | -9.77 Million USD | -915.474% |
| Immunovant, Inc. | -635.22 Million USD | 84.372% |
| Quantum-Si incorporated | -118.55 Million USD | 16.266% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -2296.157% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 1336.736% |
| Acasti Pharma Inc. | -23 Million USD | -331.527% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -2848.204% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 41.355% |
| PepGen Inc. | -60.67 Million USD | -63.627% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -419.046% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -11415.375% |
| Immuneering Corporation | -54.94 Million USD | -80.684% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -2261.676% |
| Belite Bio, Inc | -87.27 Million USD | -13.752% |
| XOMA Corporation | -29 Million USD | -242.32% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -40.42% |
| Bionomics Limited | 227 Million USD | 143.731% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -3819.178% |
| uniQure N.V. | -102.95 Million USD | 3.573% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -2283.255% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 342.418% |
| Forte Biosciences, Inc. | -11.96 Million USD | -729.971% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -3108.35% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 93753.566% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -2961.14% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1214.798% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -1238.63% |
| Altimmune, Inc. | -134.48 Million USD | 26.184% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 46.483% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -3819.178% |
| Peak Bio, Inc. | 10.34 Million USD | 1060.07% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -34978.721% |
| Benitec Biopharma Inc. | -50.58 Million USD | -96.261% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 4.855% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 605.334% |
| Zura Bio Limited | -99.8 Million USD | 0.534% |
| PolyPid Ltd. | 6.17 Million USD | 1708.959% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 605.334% |
| argenx SE | -2.02 Billion USD | 95.107% |
| Immunome, Inc. | -97.02 Million USD | -2.312% |
| Verona Pharma plc | -220.44 Million USD | 54.967% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -38.373% |
| Shattuck Labs, Inc. | -121.42 Million USD | 18.243% |
| CervoMed Inc. | -7.79 Million USD | -1173.896% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -2170.13% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 24.645% |
| Moolec Science SA | 117.61 Thousand USD | 84504.146% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -4238.889% |
| Design Therapeutics, Inc. | -18.15 Million USD | -446.957% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -41.051% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 983.839% |
| Achilles Therapeutics plc | -126.92 Million USD | 21.786% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 6908.24% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -1234.312% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 129.181% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 518.255% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 77.815% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 29.248% |
| Beam Therapeutics Inc. | -262.72 Million USD | 62.214% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 555.046% |
| AEON Biopharma, Inc. | -4.88 Million USD | -1934.278% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -77.704% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 0.588% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -4128.345% |
| NeurAxis, Inc. | 145.7 Thousand USD | 68235.058% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -154.376% |
| Lumos Pharma, Inc. | -28.49 Million USD | -248.411% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -377.874% |
| Palisade Bio, Inc. | -12.06 Million USD | -722.953% |
| Nutriband Inc. | -251.65 Thousand USD | -39347.653% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -19.201% |
| Neurogene Inc. | -131.95 Million USD | 24.768% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -1922.261% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 73.681% |
| Athira Pharma, Inc. | -88.99 Million USD | -11.544% |
| HCW Biologics Inc. | 2.85 Million USD | 3575.115% |
| XOMA Corporation | -29 Million USD | -242.32% |
| Nektar Therapeutics | 210.24 Million USD | 147.219% |
| Arvinas, Inc. | -313.8 Million USD | 68.364% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 6217.037% |
| Merus N.V. | -192.88 Million USD | 48.532% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 265.496% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -1330.856% |
| Rezolute, Inc. | -68.16 Million USD | -45.63% |
| Clene Inc. | 3.34 Million USD | 3072.239% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -652.808% |
| BeyondSpring Inc. | -13.75 Million USD | -621.721% |
| Synlogic, Inc. | -6.68 Million USD | -1385.008% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 8854.213% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1074.131% |
| Peak Bio, Inc. | 10.34 Million USD | 1060.07% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -20.447% |
| Krystal Biotech, Inc. | -350.23 Million USD | 71.655% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 179.978% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 41.257% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -3044.386% |
| MannKind Corporation | 143.89 Million USD | 168.988% |
| Ikena Oncology, Inc. | -109.15 Million USD | 9.054% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -1211.224% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -199.918% |
| Gossamer Bio, Inc. | 180.35 Million USD | 155.043% |
| CohBar, Inc. | -5.93 Million USD | -1573.871% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -233.712% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2274.174% |
| Legend Biotech Corporation | -949.39 Million USD | 89.544% |
| Mural Oncology plc | -255.84 Million USD | 61.198% |
| Disc Medicine, Inc. | -358.28 Million USD | 72.292% |
| Champions Oncology, Inc. | 4.81 Million USD | 2163.025% |
| REGENXBIO Inc. | 54.76 Million USD | 281.261% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -36817.142% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 34.267% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1001.561% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -23.041% |
| Vaxart, Inc. | -8.24 Million USD | -1104.621% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -97.833% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 21.934% |
| Cellectis S.A. | -43.85 Million USD | -126.366% |
| Longeveron Inc. | -2.9 Million USD | -3313.782% |
| Repare Therapeutics Inc. | -107.85 Million USD | 7.96% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 110.251% |
| Inozyme Pharma, Inc. | 12 Million USD | 926.998% |
| Revolution Medicines, Inc. | -608.2 Million USD | 83.678% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -7970.958% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 62.555% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 33.85% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -534.452% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -13315.241% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.962% |
| Denali Therapeutics Inc. | -74.86 Million USD | -32.602% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -727.846% |
| Veru Inc. | 4.77 Million USD | 2176.85% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -782.739% |
| Cingulate Inc. | 3.08 Million USD | 3320.337% |
| Passage Bio, Inc. | 4.58 Million USD | 2265.164% |
| Context Therapeutics Inc. | -14.44 Million USD | -587.017% |
| Exicure, Inc. | 5.84 Million USD | 1797.261% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 56.908% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -150.879% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 732.673% |
| Nuvalent, Inc. | -335.38 Million USD | 70.401% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 5823.948% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -33.284% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1016.679% |
| OmniAb, Inc. | 9.2 Million USD | 1178.7% |
| Anew Medical, Inc. | 1.43 Million USD | 7030.206% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 705.996% |
| Lipocine Inc. | -4.75 Million USD | -1987.935% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 9.611% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 751.781% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -95.963% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 498.814% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -1377.054% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -50.809% |
| Ocugen, Inc. | -32.52 Million USD | -205.257% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -16.007% |
| Q32 Bio Inc. | -37.94 Million USD | -161.602% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -15707.768% |
| Alumis Inc. Common Stock | -13.52 Million USD | -633.778% |
| Equillium, Inc. | -22.39 Million USD | -343.34% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -288.27% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -204.268% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -39943.071% |
| Dominari Holdings Inc. | 195 Thousand USD | 51009.118% |
| Edesa Biotech, Inc. | -5.26 Million USD | -1784.839% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1013.298% |
| Bio-Techne Corporation | 267.74 Million USD | 137.077% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -512.455% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 15.937% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1081.397% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -684.703% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 59.5% |
| Nkarta, Inc. | 57.29 Million USD | 273.254% |
| BioCardia, Inc. | 212 Thousand USD | 46926.783% |
| Iterum Therapeutics plc | 13.43 Million USD | 838.747% |